Publications & Presentations

  • All
  • Cancer Immunology
  • Cellular and Regenerative Medicine
  • Inflammation & Neurology
  • Oncology
  • Vaccines & Infectious Disease
Cancer Immunology / Publication / 2020
Axelrod ML, Nixon ML, Gonzalez-Ericsson PI, Bergman RE, Pilkinton MA, McDonnell WJ, Sanchez V, Opalenik S, Loi S, Zhou J, Mackay S, Rexer BN, Abramson VG, Jansen VM, Mallal SA, Donaldson J, Tolaney SM, Krop I, Garrido-Castro AC, Marotti JD, Shee K, Miller TW, Sanders M, Mayer IA, Salgado R, and Balko JM., Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer, Clinical Cancer Research, 2020
Cellular and Regenerative Medicine / Publication / 2020
Fousek K, Watanabe J, Joseph SK, George A, An X, Byrd TT, Morris JS, Luong A, Martinez-Paniagua MA, Sanber K, Navai SA, Gad AZ, Salsman VS, Mathew PR, Kim HN, Wagner DL, Brunetti L, Jang A, Baker ML, Varadarajan N, Hegde M, Kim Y-M, Heisterkamp N, Abdel-Azim H, and Ahmed N., CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression, Leukemia, 2020
Cancer Immunology / Presentation / 2019
Daver N, Kantarjian H, Mackay S, Flynn B, Basu S, Garcia-Manero G, Alfayez M, Konopleva M, Matthews J, Kornblau S, Jabbour E, Zhou J, Andreeff M; IsoPlexis, Branford, CT., Polyfunctionality determined by single-cell proteomics of bone marrow-derived CD4 T cells from patients with acute myeloid leukemia identifies patients responding to anti-PD-1-based therapy and discovers profound T cell defect in mutant TP53 disease., Presented at the AACR Conference, 2019
Inflammation & Neurology / Publication / 2018
Fujiwara M, Anstadt EJ, Flynn B, Morse K, Ng C, Paczkowski P, Zhou J, Mackay S, Wasko N, Nichols F, Clark RB.,  Enhanced TLR2 Responses in Multiple Sclerosis., Clinical and Experimental Immunology., 2018
Cellular and Regenerative Medicine / Presentation / 2017
Fraietta JA, Lacey SF, Orlando E, Pruteanu J, Gohil M, Wang Y, Boesteanu A, O'Connor R, Ambrose DE, Hwang WT, Wilcox N, Bedoya F, Dorfmeier C, Chen F, Parakandi H, Gupta M, Pequignot E, Johnson FB, Kulikovskaya I, Liu L, Lundh SM, Xu J, Davis MM, Young RM, Levine BL, Siegel DL, Huang A, Wherry EJ, Zhou J, Paczkowski P, Mackay S, Brogdon J, Bitter H, Porter DL, June CH, and Melenhorst JJ.,  Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia., Blood 130 (Suppl. 1) 3181 ., 2017